Mechanistic approaches to volume of distribution predictions: Understanding the processes

被引:326
作者
Rodgers, Trudy [1 ]
Rowland, Malcolm [1 ]
机构
[1] Univ Manchester, Sch Pharm, Ctr Appl Pharmacokinet Res, Manchester M13 9PT, Lancs, England
关键词
in silico modelling; pharmacokinetics; physicochemical properties; physiological model; tissue distribution;
D O I
10.1007/s11095-006-9210-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To use recently developed mechanistic equations to predict tissue-to-plasma water partition coefficients (Kpus), apply these predictions to whole body unbound volume of distribution at steady state (Vu(ss)) determinations, and explain the differences in the extent of drug distribution both within and across the various compound classes. Materials and Methods. Vu(ss) values were predicted for 92 structurally diverse compounds in rats and 140 in humans by two approaches. The first approach incorporated Kpu values predicted for 13 tissues whereas the second was restricted to muscle. Results. The prediction accuracy was good for both approaches in rats and humans, with 64-78% and 82-92% of the predicted Vu(ss) values agreeing with in vivo data to within factors of +/- 2 and 3, respectively. Conclusion. Generic distribution processes were identified as lipid partitioning and dissolution where the former is higher for lipophilic unionised drugs. In addition, electrostatic interactions with acidic phospholipids can predominate for ionised bases when affinities (reflected by binding to constituents within blood) are high. For acidic drugs albumin binding dominates when plasma protein binding is high. This ability to explain drug distribution and link it to physicochemical properties can help guide the compound selection process.
引用
收藏
页码:918 / 933
页数:16
相关论文
共 117 条
[11]   PHARMACOKINETICS OF N-ACETYLCYSTEINE IN MAN [J].
BORGSTROM, L ;
KAGEDAL, B ;
PAULSEN, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :217-222
[12]   Extensive binding of the bioflavonoid quercetin to human plasma proteins [J].
Boulton, DW ;
Walle, UK ;
Walle, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (02) :243-249
[13]   PHARMACOKINETICS OF METHOHEXITONE FOLLOWING INTRAVENOUS-INFUSION IN HUMANS [J].
BREIMER, DD .
BRITISH JOURNAL OF ANAESTHESIA, 1976, 48 (07) :643-649
[14]   PHARMACOKINETICS OF LIDOCAINE AND BUPIVACAINE AND STABLE ISOTOPE LABELED ANALOGS - A STUDY IN HEALTHY-VOLUNTEERS [J].
BURM, AGL ;
DEBOER, AG ;
VANKLEEF, JW ;
VERMEULEN, NPE ;
DELEEDE, LGJ ;
SPIERDIJK, J ;
BREIMER, DD .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (01) :85-95
[15]  
BUSCH U, 1995, EUR J CLIN PHARMACOL, V48, P269
[16]   PHARMACOKINETICS AND BIOINVERSION OF IBUPROFEN ENANTIOMERS IN HUMANS [J].
CHENG, HY ;
ROGERS, JD ;
DEMETRIADES, JL ;
HOLLAND, SD ;
SEIBOLD, JR ;
DEPUY, E .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :824-830
[17]  
Cheng JWM, 1997, PHARMACOTHERAPY, V17, P584
[18]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[19]   A PHYSIOLOGICAL MODEL FOR THE DISTRIBUTION OF INJECTED AGENTS, WITH SPECIAL REFERENCE TO PETHIDINE [J].
DAVIS, NR ;
MAPLESON, WW .
BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 (03) :248-258
[20]  
DUBOIS JP, 1976, CLIN CHEM, V22, P892